Document is current
Any future updates will be listed below
-
Authors
Zhang, Yuchen
Guo, Rui
Kim, Sharon H.
Shah, Hardik http://orcid.org/0000-0001-8408-5686
Zhang, Shuting
Liang, Jin Hua
Fang, Ying
Gentili, Matteo http://orcid.org/0000-0002-6970-8133
Leary, Colin N. O’
Elledge, Steven J.
Hung, Deborah T. http://orcid.org/0000-0003-4262-0673
Mootha, Vamsi K.
Gewurz, Benjamin E. http://orcid.org/0000-0002-3965-3418
- License Information
-
More Information
Article History
Received: 25 September 2020
Accepted: 19 February 2021
First Online: 15 March 2021
Competing interests
: V.K.M. and B.E.G. are listed as inventors on a patent application filed by the Broad Institute based on results from this manuscript. V.K.M. is on the scientific advisory board and receives compensation from Janssen Pharmaceuticals and 5am Ventures and owns equity in Raze Therapeutics. B.E.G. receives research support from Abbvie. S.J.E. is a founder of TSCAN Therapeutics, MAZE Therapeutics, and Mirimus. S.J.E. is a founder of TSCAN Therapeutics, MAZE Therapeutics, ImmuneID, and Mirimus. S.J.E. serves on the scientific advisory board of Homology Medicines, TSCAN Therapeutics, MAZE Therapeutics, XChem, and is an advisor for MPM, none of which affect this work. Y.Z., R.G., S.H.K., H.S., S.Z., J.H.L., Y.F., M.G., C.N.O., and D.T.H. declare no competing interests.
